Case Report: A long-term response of immunotherapy combined with anti-angiogenesis therapy in a patient with dMMR metastatic colorectal cancer after ICI failure
This report demonstrates that the combination of ICI and anti-angiogenesis therapy can induce a powerful and durable antitumor response in patients with ICI-resistant MSI-H/dMMR mCRC, which is worthy of further research.
Authors
- Qianwen Huang (ORCID: https://orcid.org/0000-0001-7156-7950)
- Xiaoling Zheng
- Wenshen Xu
Institutions
- Huizhou Central People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-04-09
- DOI
- https://doi.org/10.3389/fonc.2025.1553380
- Citations
- 2
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 2.09